Trials / Completed
CompletedNCT02223533
Multimodal Analgesia With Interfascial Continuous Wound Infiltration: A Randomized Clinical Trial
Multimodal Analgesia With Interfascial Continuous Wound Infiltration of a Local Anaesthetic vs Intravenous Opioids After Laparoscopic Colon Surgery: A Randomized Clinical Trial.
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Hospital Galdakao-Usansolo · Other Government
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objectives: For major laparoscopic surgery, as with open surgery a multimodal analgesia plan can help control postoperative pain. Placing a wound catheter intraoperatively following colon surgery could optimize the control of acute pain with less consumption of opioids and few adverse effects. Methods: We conducted a prospective, randomized, study of 103 patients scheduled to undergo laparoscopic colon surgery for cancer in Galdakao-Usansolo Hospital. Patients were recruited and randomly allocated to wound catheter placement plus standard postoperative analgesia or standard postoperative analgesia alone. A physician from the acute pain management unit monitored all patients for at multiple points over the first 48 hours after surgery. The primary outcome variables were verbal numeric pain scale (NRS) scores and amount of intravenous morphine used via patient controlled infusion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | 19Gx500-mm Pajunk InfiltraLong® catheter | Before completing the surgery, the surgical team inserted a 19Gx500-mm Pajunk InfiltraLong® catheter with multiple perforations in the last few centimeters before the tip to allow for local anesthetic administration. |
| DRUG | morphine | After the intervention patients had access to intravenous morphine via a patient-controlled analgesia |
Timeline
- Start date
- 2012-01-01
- Primary completion
- 2013-01-01
- Completion
- 2014-01-01
- First posted
- 2014-08-22
- Last updated
- 2014-08-22
Locations
1 site across 1 country: Spain
Source: ClinicalTrials.gov record NCT02223533. Inclusion in this directory is not an endorsement.